2022
DOI: 10.1111/jdv.18798
|View full text |Cite
|
Sign up to set email alerts
|

Discussing reproductive potential with transgender patients in dermatology clinics – A plea for more considerate terminology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 4 publications
0
2
0
Order By: Relevance
“…Dermatologists should consider the impacts of pregnancy testing on gender dysphoria and ensure sensitivity around these discussions if there is any sexual activity with sperm-producing partners. 44 Emergency contraception should not interfere with GAH therapy and may be safely used by TGD individuals. 41 The association between isotretinoin and adverse mental health outcomes including suicidal ideation remains controversial.…”
Section: Acne Vulgarismentioning
confidence: 99%
See 1 more Smart Citation
“…Dermatologists should consider the impacts of pregnancy testing on gender dysphoria and ensure sensitivity around these discussions if there is any sexual activity with sperm-producing partners. 44 Emergency contraception should not interfere with GAH therapy and may be safely used by TGD individuals. 41 The association between isotretinoin and adverse mental health outcomes including suicidal ideation remains controversial.…”
Section: Acne Vulgarismentioning
confidence: 99%
“…Isotretinoin and testosterone are category X and D teratogens respectively and patients require ongoing monitoring for pregnancy. Dermatologists should consider the impacts of pregnancy testing on gender dysphoria and ensure sensitivity around these discussions if there is any sexual activity with sperm‐producing partners 44 . Emergency contraception should not interfere with GAH therapy and may be safely used by TGD individuals 41 .…”
Section: Dermatological Considerations In Testosterone Therapymentioning
confidence: 99%